NCT01384513 2026-04-15A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesThomas Jefferson UniversityPhase 2 Completed40 enrolled 15 charts
NCT06563804 2026-03-30A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMMLServierPhase 1/2 Terminated13 enrolled
NCT04988555 2026-03-24A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)Sumitomo Pharma America, Inc.Phase 1/2 Recruiting606 enrolled
NCT04278768 2026-03-19Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)Curis, Inc.Phase 1/2 Suspended366 enrolled